Abstract
Polycystic ovary syndrome (PCOS) is a complex and heterogeneous disease that involves menstrual dysfunction and reproductive difficulty as well as metabolic problems. From a genetic point of view, it is a complex disease that is subject to environmental influences, mainly dietary, which makes it similar to other metabolic processes, such as diabetes and obesity. So, the interest of the diagnosis of the PCOS is, not only to improve fertility but to prevent possible future medical complications like the diabetes mellitus and the obesity.
Due to the classical definition of PCOS as functional hyperandrogenism, the race to discover genetic alterations that could lead to the development of PCOS started with the androgen metabolism genes. However, the list of candidates was later expanded to other genes outside this hormonal pathway, and it now includes genes involved in carbohydrate and lipid metabolism as well as those involved in inflammatory processes.
Synopsis: The list of genes candidates involved in PCOS is related to diabetes and inflammatory processes.
Keywords: Polymorphism, Polycystic ovary syndrome, Insulin resistance, Diabetes Mellitus, obesity, hyperandrogenism, trauma, haemorrhage, Hyperinsulinism, GWAs
Current Diabetes Reviews
Title: Common Genetic Aspects Between Polycystic Ovary Syndrome and Diabetes Mellitus
Volume: 7 Issue: 6
Author(s): Nicolas Mendoza
Affiliation:
Keywords: Polymorphism, Polycystic ovary syndrome, Insulin resistance, Diabetes Mellitus, obesity, hyperandrogenism, trauma, haemorrhage, Hyperinsulinism, GWAs
Abstract: Polycystic ovary syndrome (PCOS) is a complex and heterogeneous disease that involves menstrual dysfunction and reproductive difficulty as well as metabolic problems. From a genetic point of view, it is a complex disease that is subject to environmental influences, mainly dietary, which makes it similar to other metabolic processes, such as diabetes and obesity. So, the interest of the diagnosis of the PCOS is, not only to improve fertility but to prevent possible future medical complications like the diabetes mellitus and the obesity.
Due to the classical definition of PCOS as functional hyperandrogenism, the race to discover genetic alterations that could lead to the development of PCOS started with the androgen metabolism genes. However, the list of candidates was later expanded to other genes outside this hormonal pathway, and it now includes genes involved in carbohydrate and lipid metabolism as well as those involved in inflammatory processes.
Synopsis: The list of genes candidates involved in PCOS is related to diabetes and inflammatory processes.
Export Options
About this article
Cite this article as:
Mendoza Nicolas, Common Genetic Aspects Between Polycystic Ovary Syndrome and Diabetes Mellitus, Current Diabetes Reviews 2011; 7 (6) . https://dx.doi.org/10.2174/157339911797579142
DOI https://dx.doi.org/10.2174/157339911797579142 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Fetal and Obstetric Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews The Effect of Pyrroloquinoline Quinone on Apoptosis and Autophagy in Traumatic Brain Injury
CNS & Neurological Disorders - Drug Targets Mechanisms of Platelet Activation in Acute Coronary Syndromes
Current Vascular Pharmacology Pathogens and Chronic or Long-Term Neurologic Disorders
Cardiovascular & Hematological Disorders-Drug Targets Uterine Function: From Normal to Polycystic Ovarian Syndrome Alterations
Current Medicinal Chemistry Targeting Chemokine (C-X-C motif) Receptor 3 in Thyroid Autoimmunity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Diet Control in Pregnant Women with Gestational Diabetes Mellitus
Current Women`s Health Reviews The Role of Tocilizumab in Cytokine Storm and Improving Outcomes in COVID-19
Recent Patents on Anti-Infective Drug Discovery Effects of Maternal Obesity on Maternal and Fetal Health
Current Women`s Health Reviews Gene-Activation Mechanisms in the Regression of Atherosclerosis, Elimination of Diabetes Type 2, and Prevention of Dementia
Current Molecular Medicine Extrinsic Factors Promoting Insulin Producing Cell-Differentiation and Insulin Expression Enhancement-Hope for Diabetics.
Current Stem Cell Research & Therapy Tailoring Antiplatelet Therapy: A Step Toward Individualized Therapy to Improve Clinical Outcome?
Current Pharmaceutical Design Angiotensin II Type I Receptor Blocker and Endothelial Function in Humans: Role of Nitric Oxide and Oxidative Stress
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Inflammatory Risk Factors and Pathologies Associated with Alzheimers Disease
Current Alzheimer Research Gestational Diabetes Mellitus Pharmacological Prevention and Treatment
Current Pharmaceutical Design A Brief Survey for MicroRNA Precursor Identification Using Machine Learning Methods
Current Genomics Cerebral Artery Signal Transduction Mechanisms: Developmental Changes in Dynamics and Ca<sup>2+</sup> Sensitivity
Current Vascular Pharmacology Modulation of Cytokine Network in the Comorbidity of Schizophrenia and Tuberculosis
Current Topics in Medicinal Chemistry Comparison of Biolimus Versus Everolimus for Drug-Eluting Stents in the Percutaneous Treatment of Infra-Inguinal Arterial Disease
Current Vascular Pharmacology Hypopituitarism in Neurocritical Patients: A Case Report
Endocrine, Metabolic & Immune Disorders - Drug Targets